Search research articles
Contact Us
Filters
Showing results (581-590 of 603) with videos related to
Page
of 61
Sort By:
BMC Cancer
|
May 7, 2021
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker
Kristen C Kelley, Kenneth F Grossman, Mary Brittain-Blankenship, et al.
Cancer Research Communications
|
November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer
Maj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.
Cancer Research
|
January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Nicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2022
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Stephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, et al.
The Journal of Trauma and Acute Care Surgery
|
April 19, 2023
Contemporary management and outcomes of penetrating colon injuries: Validation of the 2020 AAST Colon Organ Injury Scale
Ahmad Zeineddin, Gail T Tominaga, Marie Crandall, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Ovarian cancer, version 3.2012
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 22, 2013
Ovarian cancer, version 2.2013
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Nature Communications
|
November 3, 2017
Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Nature Communications
|
February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Page
of 61
Search research articles
Search
Showing results (581-590 of 603) with videos related to
Sort By:
Page
of 61
BMC Cancer
|
May 7, 2021
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker
Kristen C Kelley, Kenneth F Grossman, Mary Brittain-Blankenship, et al.
Cancer Research Communications
|
November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer
Maj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.
Cancer Research
|
January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Nicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2022
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Stephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, et al.
The Journal of Trauma and Acute Care Surgery
|
April 19, 2023
Contemporary management and outcomes of penetrating colon injuries: Validation of the 2020 AAST Colon Organ Injury Scale
Ahmad Zeineddin, Gail T Tominaga, Marie Crandall, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Ovarian cancer, version 3.2012
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 22, 2013
Ovarian cancer, version 2.2013
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Nature Communications
|
November 3, 2017
Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Nature Communications
|
February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Page
of 61